SCHEMBL6044928

SCHEMBL6044928

CC(=O)[N]C([N]C(C)=O)C(C)O

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2390543 0.71
SCHEMBL3890009 0.67
Acetone SCHEMBL28317344 0.66 LMNA (0.55) TP53
Acetone SCHEMBL11643604 0.63 LMNA (0.50) TP53
Acetic Acid SCHEMBL24229 0.63 FFAR3 (0.58) TP53
Acetone SCHEMBL29098211 0.61 LMNA (0.60) TP53
Acetone SCHEMBL8505655 0.61 LMNA (0.60) TP53
Acetone SCHEMBL39581 0.61
Acetone SCHEMBL10768381 0.61 LMNA (0.60) TP53
Acetone SCHEMBL10855260 0.61 LMNA (0.60) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636344-A4 PHARMACEUTICALLY COMPATIBLE METHOD FOR PURIFYING INTACT BACTERIAL MINICELLS ENGENEIC MOLECULAR DELIVERY PTY LTD (AU) 2006-07-19 EP disclosed
EP-1636344-A1 PHARMACEUTICALLY COMPATIBLE METHOD FOR PURIFYING INTACT BACTERIAL MINICELLS EnGeneIC Molecular Delivery Pty Ltd. (AU) 2006-03-22 EP disclosed
WO-2004113507-A1 PHARMACEUTICALLY COMPATIBLE METHOD FOR PURIFYING INTACT BACTERIAL MINICELLS ENGENEIC MOLECULAR DELIVERY PTY LTD. (US) 2004-12-29 WO disclosed